Health screening results of Cubans settling in Texas, USA, 2010–2015: A cross-sectional analysis
Autoři:
Emma E. Seagle aff001; Jessica Montour aff003; Deborah Lee aff001; Christina Phares aff001; Emily S. Jentes aff001
Působiště autorů:
Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
aff001; Applied Epidemiology Fellowship Program, Council of State and Territorial Epidemiologists, Atlanta, Georgia, United States of America
aff002; Texas Refugee Health Program, Texas Department of State Health Services, Austin, Texas, United States of America
aff003
Vyšlo v časopise:
Health screening results of Cubans settling in Texas, USA, 2010–2015: A cross-sectional analysis. PLoS Med 17(8): e32767. doi:10.1371/journal.pmed.1003233
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pmed.1003233
Souhrn
Background
Protecting the health of refugees and other migrant populations in the United States is key to ensuring successful resettlement. Therefore, to identify and address health concerns early, the US Centers for Disease Control and Prevention (CDC) recommends a domestic medical examination (screening for infectious and noninfectious diseases/conditions) shortly after arrival in the US. However, because refugee/migrant populations often have differing health patterns from one another and the US population, the collection and analysis of health information is key to developing population-specific clinical guidelines to guide the care of resettled individuals. Yet little is known regarding the health status of Cubans resettling in the US. Among the tens of thousands of Cuban migrants who have resettled in the US, some applied as refugees in Cuba, some applied for parole (a term used to indicate temporary US admission status for urgent humanitarian reasons or reasons of public benefit under US immigration law) in Cuba, and others applied for parole status after crossing the border. These groups were eligible for US government benefits to help them resettle, including a domestic medical examination. We reviewed health differences found in these examinations of those who were determined to be refugees or parolees in Cuba and those who were given parole status after arrival.
Methods and findings
We conducted a retrospective cross-sectional analysis of the Texas Department of State Health Services database. Cubans who arrived from 2010 to 2015 and received a domestic medical examination in Texas were included. Those granted refugee/parolee status in Cuba were listed in federal databases for US-bound refugees/parolees; those who were paroled after arrival were not listed. Overall, 2,189 (20%) obtained either refugee or parolee status in Cuba, and 8,709 (80%) received parolee status after arrival. Approximately 62% of those who received parolee status after arrival at the border were male, compared with 49% of those who obtained prior refugee/parolee status in Cuba. Approximately one-half (45%) of those paroled after arrival were 19–34 years old (versus 26% among those who obtained refugee/parolee status in Cuba). Separate models were created for each screening indicator as the outcome, with entry route as the main exposure variable. Crude and adjusted prevalence ratios were estimated using PROC GENMOD procedures in SAS 9.4. Individuals paroled after arrival were less likely to screen positive for parasitic infections (9.6% versus 12.2%; adjusted prevalence ratio: 0.79, 0.71–0.88) and elevated blood lead levels (children ≤16 years old, 5.2% versus 12.3%; adjusted prevalence ratio: 0.42, 0.28–0.63). Limitations include potential disease misclassification, missing clinical information, and cross-sectional nature.
Conclusions
Within-country variations in health status are often not examined in refugee populations, yet they are critical to understand granular health trends. Results suggests that the health profiles of Cuban Americans in Texas differed by entry route. This information could assist in developing targeted screenings and health interventions.
Klíčová slova:
Hepatitis B – Parasitic diseases – Screening guidelines – Syphilis – Texas – United States – Refugees – Cuba
Zdroje
1. Office of Refugee Resettlement. Fiscal year 2014 refugee arrivals. Washington: Office of Refugee Resettlement; 2015 Feb 11 [cited 2018 Jun 1]. Available from: https://www.acf.hhs.gov/orr/resource/fiscal-year-2014-refugee-arrivals.
2. Batalova J, Zong J. Cuban immigrants in the United States. Washington: Migration Policy Institute; 2020 Jun 11 [cited 2018 Jun 14]. Available from: https://www.migrationpolicy.org/article/cuban-immigrants-united-states#Distribution.
3. Florida Department of Children and Families. Refugee program eligibility guide for service providers. Florida Department of Children and Families; [cited 2018 Jun 2]. Available from: https://www.myflfamilies.com/service-programs/refugee-services/overview.shtml.
4. Luna K. Growing numbers of Cuban migrants in the United States. Washington: Center for Immigration Studies; 2016 May 7 [cited 2018 Jun 4]. Available from: https://cis.org/Report/Growing-Numbers-Cuban-Migrants-United-States.
5. US Citizenship and Immigration Services. Cuban Haitian Entrant Program (CHEP). Washington: US Citizenship and Immigration Services; [cited 2018 Jun 27]. Available from: https://www.uscis.gov/archive/cuban-haitian-entrant-program-chep.
6. Wasem RE. Cuban migration to the United States: policy and trends. Washington: Congressional Research Service; [cited 2018 Aug 4]. Available from: https://fas.org/sgp/crs/row/R40566.pdf.
7. Centers for Disease Control and Prevention. Technical Instructions for Panel Physicians and Civil Surgeons. Atlanta: CDC; 2016 Nov 23 [cited 2018 Jun 1]. Available from: https://www.cdc.gov/immigrantrefugeehealth/exams/ti/index.html.
8. Lee D, Philen R, Wang Z, McSpadden P, Posey DL, Ortega LS, et al. Disease surveillance among newly arriving refugees and immigrants—Electronic Disease Notification System, United States, 2009. MMWR Surveill Summ. 2013;62(7):1–20. 24225411
9. wrapsnet.org [Internet]. Worldwide refugee admissions processing system. Arlington, VA: Refugee Processing Center; 2016 [cited 2018 Jun 2]. Available from: http://www.wrapsnet.org/.
10. Centers for Disease Control and Prevention. Guidelines for the U.S. domestic medical examination for newly arriving refugees. Altanta: CDC; [cited 2018 Jun 1]. Available from: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/domestic-guidelines.html.
11. Benoit SR, Gregg EW, Zhou W, Painter JA. Diabetes among United States-bound adult refugees, 2009–2014. J Immigr Minor Health. 2016;18(6):1357–1364. doi: 10.1007/s10903-016-0381-7 26976006
12. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1998;47:1–29.
13. Centers for Disease Control and Prevention. Body mass index (BMI). Atlanta: CDC; [cited 2018 Jun 21]. Available from: https://www.cdc.gov/healthyweight/assessing/bmi/index.html.
14. Centers for Disease Control and Prevention. High blood pressure fact sheet. Atlanta: CDC; [cited 2018 May 30]. Available from: https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm.
15. Mitruka K, Pezzi C, Baack B, Burke H, Cochran J, Matheson J, et al. Evaluation of hepatitis B virus screening, vaccination, and linkage to care among newly arrived refugees in four states, 2009–2011. J Immigr Minor Health. 2019;21:39–46. doi: 10.1007/s10903-018-0705-x 29417356
16. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6. doi: 10.1093/aje/kwh090 15033648
17. Trepka MJ, Pekovic V, Santana JC, Zhang G. Risk factors for lead poisoning among Cuban refugee children. Public Health Rep. 2005;120(2):179–85. doi: 10.1177/003335490512000212 15842120
18. Markowitz G, Rosner D. "Cater to the children": the role of the lead industry in a public health tragedy, 1900–1955. Am J Public Health. 2000;90(1):36–46. doi: 10.2105/ajph.90.1.36 10630135
19. United Nations Environment Programme. Global report on the status of legal limits on lead in paint. Nairobi: United Nations Environment Programme; 2016 May [cited 2018 May 30]. Available from: http://wedocs.unep.org/bitstream/handle/20.500.11822/11348/Limits-Lead-Paint-2016%20Report-Final.pdf?isAllowed=y&sequence=1.
20. Oudijk G. The rise and fall of organometallic additives in automotive gasoline. Environmental Forensics. 2010;11(1):17–49.
21. Alvarez AM, Estevez Alvarez JR, do Nascimento CW, Gonzalez IP, Rizo OD, Carzola LL, et al. Lead isotope ratios in lichen samples evaluated by ICP-ToF-MS to assess possible atmospheric pollution sources in Havana, Cuba. Environ Monit Assess. 2017;189(1):28. doi: 10.1007/s10661-016-5739-8 28000124
22. Roberts JR, Reigart JR, Ebeling M, Hulsey TC. Time required for blood lead levels to decline in nonchelated children. J Toxicol Clin Toxicol. 2001;39(2):153–60. doi: 10.1081/clt-100103831 11407501
23. Morshed MG, Singh AE. Recent trends in the serologic diagnosis of syphilis. Clin Vaccine Immunol. 2015;22(2):137–47. doi: 10.1128/CVI.00681-14 25428245
24. Centers for Disease Control and Prevention. Syphilis. Atlanta: CDC; [cited 2018 Jun 1]. Available from: https://www.cdc.gov/std/stats16/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf.
25. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93. doi: 10.1097/OLQ.0b013e318286bb53 23403598
26. World Health Organization. Proportion of children (1–14 years of age) in the country requiring preventive chemotherapy (PC) for soil-transmitted helminthiases, worldwide, 2014. Geneva: WHO; 2015 [cited 2018 Aug 22]. Available from: http://gamapserver.who.int/mapLibrary/Files/Maps/STH_2014.png?ua=1.
27. Saboya MI, Catala L, Nicholls RS, Ault SK. Update on the mapping of prevalence and intensity of infection for soil-transmitted helminth infections in Latin America and the Caribbean: a call for action. PLoS Negl Trop Dis. 2013;7(9):e2419. doi: 10.1371/journal.pntd.0002419 24069476
28. Centers for Disease Control and Prevention. Obesity and Overweight. Atlanta: CDC; [cited 2018 May 30]. Available from: https://www.cdc.gov/nchs/fastats/obesity-overweight.htm.
29. Centers for Disease Control and Prevention. CDC’s National Surveillance Data (2012–2016). Atlanta: CDC; [cited 2019 Feb 6]. Available from: https://www.cdc.gov/nceh/lead/data/national.htm.
30. Centers for Disease Control and Prevention. Trends in Tuberculosis, 2016. Atlanta: CDC; [cited 2018 Jun 21]. Available from: https://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm.
31. Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012. doi: 10.1371/journal.pmed.1001012 21445325
32. US Department of Homeland Security. 2015 yearbook of immigration statistics. Washington: U.S. Department of Homeland Security; 2016 Dec [cited 2018 Jun 22]. Available from: https://www.dhs.gov/sites/default/files/publications/Yearbook_Immigration_Statistics_2015.pdf.
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 8
- Jak a kdy u celiakie začíná reakce na lepek? Možnou odpověď poodkryla čerstvá kanadská studie
- Infekce se v Americe po příjezdu Kolumba šířily nesrovnatelně déle, než se traduje
- Jak může lékárník přispět ke zvýšení bezpečnosti terapie kortikosteroidy a zbavit pacienty obav z jejich nežádoucích účinků?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Budou nanoléčiva lépe cílit na některé onkologické nemoci?
Nejčtenější v tomto čísle
- Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest–posttest comparison group study
- Coming together to improve access to medicines: The genesis of the East African Community’s Medicines Regulatory Harmonization initiative
- Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
- A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial